-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Constellium, Lowers Price Target to $32

Benzinga·10/08/2026 18:06:21
Listen to the news
UBS analyst Alex Stansbury maintains Constellium (NYSE:CSTM) with a Buy and lowers the price target from $34 to $32.